US Stock MarketDetailed Quotes

PTPI Petros Pharmaceuticals

Watchlist
  • 0.4575
  • +0.0120+2.69%
Close Jun 28 16:00 ET
  • 0.4580
  • +0.0005+0.11%
Post 19:26 ET
3.20MMarket Cap-61P/E (TTM)

Petros Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Petros Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

1.39M

-44.84%
EPS(YoY)

-1.69

-156.06%
Analyst Rating

Buy

Feb 29, 2024

Petros Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 1.340M--
--2024/Q2-- / 1.397M--
--2024/Q11.389M / 1.454M--
--2023/Q4-- / 1.553M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 1.340M--
--2024/Q2-- / 1.397M--
--2024/Q11.389M / 1.454M--
--2023/Q4-- / 1.553M--

Petros Pharmaceuticals Earnings Reports

  • Petros Pharmaceuticals | 10-K/A: Annual report (Amendment)

    May 31 17:10 ET

  • Petros Pharmaceuticals | 10-Q: Quarterly report

    May 15 17:06 ET

  • Petros Pharmaceuticals | 10-K: Annual report

    Apr 1 16:35 ET

  • Petros Pharmaceuticals: Q3 2023 Earnings Report

    Nov 15, 2023 17:11 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Feb 29, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg